DocDollars

Y-Mabs Therapeutics, Inc.

NJ · United States · Reporting entity ID 100000956824

Total reported 2019–2025
$9.99M
#488 of 2,960 reporting companies — 0% of all reported industry payments
$822K in general payments across 741 records, plus $9.17M in research funding across 1,086 records.

How it breaks down

General payments $822,069
Research funding $9,171,919

Where this comes from

Figures are from the CMS Open Payments “payments grouped by reporting entity” dataset, queried live. Reporting entities are applicable manufacturers and group purchasing organisations required to report under the Sunshine Act.

Summary

Y-Mabs Therapeutics, Inc. reported $9.99M to US doctors and teaching hospitals from 2019 to 2025, ranking #488 of 2,960 reporting companies. 92% of that was research funding and 8% general payments such as consulting, speaking, food and travel. 741 general payment records and 1,086 research records were filed.

Common questions about Y-Mabs Therapeutics, Inc.

How much has Y-Mabs Therapeutics, Inc. paid US doctors?

Y-Mabs Therapeutics, Inc. reported $9,993,988 to US physicians and teaching hospitals across the 2019–2025 Open Payments program years: $822,069 in general payments, $9,171,919 in research funding.

How does Y-Mabs Therapeutics, Inc. rank among drug and device companies?

It ranks #488 of 2,960 reporting entities by total reported value, about 0% of all industry payments in the dataset.

Does a payment from Y-Mabs Therapeutics, Inc. mean a doctor did something wrong?

No. Open Payments records transfers of value such as speaking fees, consulting, meals, travel and research funding. The data shows the relationship, not its effect on prescribing or care.